What Is the Future of the Gastrointestinal Therapeutics Market? Growth Forecasts According to a newly published market research report by 24LifeSciences, global gastrointestinal therapeutics market is valued at USD 35,410 million in 2026 and is projected to reach USD 51,860 million by 2034, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. Gastrointestinal therapeutics comprise a critical class of pharmaceuticals designed to treat a wide range of disorders affecting the digestive system, from the esophagus to the colon. This includes prevalent conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and inflammatory bowel disease (IBD). The therapeutic arsenal includes well-established drugs like proton pump inhibitors, biologics, and antacids, commercially available under brands such as Aciphex (rabeprazole) and Prilosec (omeprazole). The sustained efficacy and expanding applications of these treatments continue to underpin their importance in both primary care and specialized gastroenterology practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8881/gastrointestinal-therapeutics-market

Top 10 Companies Shaping the Global Parathyroid Disorders Market (2026–2034) According to a newly published market research report by 24LifeSciences, global parathyroid disorders market is valued at USD 2.1 billion in 2026 and is projected to reach USD 3.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Parathyroid disorders are medical conditions resulting from the dysfunction of the parathyroid glands, four small glands located in the neck that regulate the body's calcium levels. These disorders lead to abnormal calcium levels in the blood, which can cause significant health issues such as brittle bones (osteoporosis), kidney stones, chronic fatigue, and muscle weakness. The primary disorders include hyperparathyroidism (overactive glands), hypoparathyroidism (underactive glands), and the rare parathyroid cancer. Market growth is primarily driven by an aging global population more susceptible to these conditions and the rising prevalence of chronic kidney disease (CKD), a major cause of secondary hyperparathyroidism. Furthermore, advancements in diagnostic techniques, such as more sensitive parathyroid hormone (PTH) assays, are facilitating earlier and more accurate detection. Key players like Amgen, with its calcimimetic drug Cinacalcet, and Abbott Laboratories, a leader in diagnostic solutions, are actively shaping the treatment landscape through innovation and strategic initiatives, contributing to market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9574/parathyroid-disorders-market

Orphan Diseases Market to Reach USD 834 million by 2034 | Growth Trends & Insights According to a newly published market research report by 24LifeSciences, global orphan diseases market is valued at USD 315 million in 2026 and is projected to reach USD 834 million by 2034, growing at a compound annual growth rate (CAGR) of 15.3% during the forecast period. An orphan disease is officially defined as a condition affecting fewer than 200,000 people in the United States, encompassing a wide spectrum of disorders from more recognized conditions like cystic fibrosis and ALS (Lou Gehrig's disease) to rare genetic disorders such as Hutchinson-Gilford progeria syndrome. The vast majority of these diseases are genetic in origin, creating significant challenges and opportunities for targeted therapeutic development. These conditions represent some of the most complex medical challenges facing modern healthcare, requiring specialized approaches to both diagnosis and treatment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9568/orphan-diseases-market

What Is Fueling the Global Endovascular Robot Market’s Rapid 17.1% CAGR Expansion? Intel Market Research, the global Endovascular Robot market was valued at USD 1.14 billion in 2026 and is projected to reach USD 3.25 billion by 2034, growing at an impressive CAGR of 17.1% during the forecast period (2026-2034). This exceptional growth is driven by increasing demand for minimally invasive vascular procedures, technological advancements in robotic systems, and the rising prevalence of cardiovascular diseases worldwide. https://www.intelmarketresearch.com/uv-skin-machines-market-30300

How Rapid and Molecular Diagnostics Are Shaping the Brucellosis Test Kits Market According to a newly published market research report by 24LifeSciences, global brucellosis test kits market is valued at USD 315.7 million in 2026 and is projected to reach USD 458.6 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. Brucellosis test kits are in-vitro diagnostic (IVD) tools designed for the serological detection of antibodies against Brucella bacteria, a critical component in diagnosing both human and animal brucellosis. These kits play an essential role in managing this zoonotic disease, which causes significant economic losses in livestock production and poses serious public health risks. The most common formats include Brucella IgG, IgM, and IgA ELISA kits, along with traditional methods like rose bengal plate tests (RBPT) and advanced fluorescence polarization assays (FPA). Their accuracy and reliability make them indispensable for veterinary diagnostics, food safety programs, and human healthcare systems worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9628/brucellosis-test-kits-market

How Are Non-Invasive Diagnostics and Imaging Advances Fueling a 4.3% CAGR in the UV Skin Analysis Machines Market? Intel Market Research, the global UV skin analysis machines market was valued at USD 50.2 million in 2026 and is projected to reach USD 69.5 million by 2034, growing at a steady CAGR of 4.3% during the forecast period (2025-2034). This growth is driven by increasing awareness of skin health, rising demand for non-invasive diagnostic tools, and technological advancements in dermatological imaging. https://www.intelmarketresearch.com/uv-skin-machines-market-30300

Minimally Invasive Cardiac Surgery Instruments Market’s CAGR of 6.8%: Leading Firms According to a newly published market research report by 24LifeSciences, global minimal invasive cardiac surgery instruments market is valued at USD 2.4 billion in 2026 and is projected to reach USD 4.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Minimally invasive cardiac surgery (MICS) instruments are specialized medical devices designed to perform complex heart surgeries through small incisions, significantly reducing patient trauma compared to traditional open-heart procedures. This category includes robotic-assisted systems, thoracoscopic instruments, and direct minimally invasive tools like specialized retractors, aortic clamps, and high-definition endoscopic cameras. Their implementation enables surgeons to operate with enhanced precision through ports, leading to substantial patient benefits including shorter hospital stays, faster recovery times, reduced blood loss, and improved cosmetic outcomes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10509/minimal-invasive-cardiac-surgery-instruments-market

What Is Driving the Global Portable Veterinary Brooder Market’s 4.4% CAGR Growth from 2025 to 2034? Intel Market Research, the global Portable Veterinary Brooder market was valued at USD 76.9 million in 2026 and is projected to reach USD 105 million by 2034, growing at a CAGR of 4.4% during the forecast period (2025-2034). This steady growth reflects increased adoption across veterinary clinics and animal care facilities, driven by technological advancements and rising pet ownership globally. https://www.intelmarketresearch.com/portable-veterinary-brooder-market-30752

How Is the Global Fish Compound Premix Market Expanding at a 6.4% CAGR Through 2034? Intel Market Research, the global Fish Compound Premix market was valued at USD 1,021 million in 2026 and is projected to reach USD 1,598 million by 2034, growing at a steady CAGR of 6.4% during the forecast period. In 2025, global production reached approximately 512,800 metric tons, reflecting the increasing importance of aquaculture nutrition in global food security initiatives. https://www.intelmarketresearch.com/fish-compound-premix-market-27513

Is Rail Coatings market the Next Growth Frontier? Market Size & Analysis. The Southeast Asia Rail Coatings market was valued at US$ 187.4 million in 2024 and is projected to grow at a steady CAGR of 5.4% to reach US$ 256.3 million by 2030. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/279699/asia-southeast-rail-coatings-market-2024-2030-618

Nepheline market Research Report 2025–2032: Opportunities, Challenges & Value Chain Analysis Global Nepheline market was valued at USD 56,580 million in 2022 and is projected to reach USD 97,820 million by 2029, exhibiting a steady CAGR of 8.1% during the forecast period. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/214882/nepheline-market-2023-2029-621

Why Is the Lithium Battery Electric Saw Market Expected to Reach USD 2.74 Billion at a 4.6% CAGR? Intel Market Research, the global Lithium Battery Electric Saw market was valued at USD 1929 million in 2026 and is projected to reach USD 2738 million by 2034, growing at a CAGR of 4.6% during the forecast period. This growth is driven by stricter environmental policies favoring electric tools, increasing DIY culture globally, and technological advancements in lithium-ion battery efficiency. https://www.intelmarketresearch.com/lithium-battery-electric-saw-market-27791